{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:38:49Z","timestamp":1781627929615,"version":"3.54.5"},"reference-count":20,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T00:00:00Z","timestamp":1588464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"This work was supported by a grant from Wockhardt Ltd., India. The funder did not influence over the conduct and reporting of this study."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Levonadifloxacin (WCK 771; IV) and its prodrug alalevonadifloxacin (WCK 2349; oral) are benzoquinolizine fluoroquinolones, recently approved in India for the treatment of acute bacterial skin and skin structure infections with concurrent bacteraemia and diabetic foot infections. Ahead of its market launch, the present study aimed to assess the in vitro activity of levonadifloxacin against contemporary Staphylococcus aureus isolates collected from a large tertiary care hospital in India. Additionally, levonadifloxacin activity was tested against hVISA and Bengal Bay clone MRSA isolates.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Non-duplicate S. aureus (n\u2009=\u2009793) isolates collected at Christian Medical College hospital, Vellore, India during 2013\u201319 were included in the study. MRSA isolates were identified using a cefoxitin disc diffusion assay. MICs of levonadifloxacin and comparator antibiotics were determined using the broth microdilution method. Mutations in QRDRs were identified for selected levofloxacin-non-susceptible isolates. MLST profiling was undertaken to detect the Bengal Bay clone.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among the 793 isolates, 441 (55.6%) were MRSA and 626 (78.9%) were non-susceptible to levofloxacin. Levonadifloxacin showed MIC50 and MIC90 values of 0.25 and 0.5\u2009mg\/L, respectively, for all S. aureus, which included hVISA and Bengal Bay clone MRSA. The potency of levonadifloxacin was 16 times superior compared with levofloxacin.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The present study demonstrated potent activity of levonadifloxacin against contemporary S. aureus isolates, which included MRSA isolates, hVISA isolates, Bengal Bay clone isolates and a high proportion of quinolone-non-susceptible isolates. The potent activity of levonadifloxacin observed in this study supports its clinical use for the treatment of S. aureus infections.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkaa142","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T12:07:28Z","timestamp":1585051648000},"source":"Crossref","is-referenced-by-count":10,"title":["Levonadifloxacin, a recently approved benzoquinolizine fluoroquinolone, exhibits potent in vitro activity against contemporary Staphylococcus aureus isolates and Bengal Bay clone isolates collected from a large Indian tertiary care hospital"],"prefix":"10.1093","author":[{"given":"Yamuna Devi","family":"Bakthavatchalam","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology, Christian Medical College, Vellore 632004, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abirami","family":"Shankar","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology, Christian Medical College, Vellore 632004, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeshwari","family":"Muniyasamy","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology, Christian Medical College, Vellore 632004, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Victor","family":"Peter","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Christian Medical College, Vellore 632004, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zervos","family":"Marcus","sequence":"first","affiliation":[{"name":"Division of Infectious Disease, Henry Ford Health System, Detroit, MI 48202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hariharan","family":"Triplicane Dwarakanathan","sequence":"first","affiliation":[{"name":"Department of Orthopaedics, Christian Medical College, Vellore 63200, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Gunasekaran","sequence":"first","affiliation":[{"name":"Department of Medicine, Unit V, Christian Medical College, Vellore 632004, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Iyadurai","sequence":"first","affiliation":[{"name":"Department of Medicine, Unit V, Christian Medical College, Vellore 632004, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Veeraraghavan","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology, Christian Medical College, Vellore 632004, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,5,3]]},"reference":[{"key":"2020050308275237500_dkaa142-B1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jgar.2016.07.008","article-title":"Prevalence and genotype distribution of methicillin-resistant Staphylococcus aureus (MRSA) in India","volume":"7","author":"Sunagar","year":"2016","journal-title":"J Glob Antimicrob Resist"},{"key":"2020050308275237500_dkaa142-B2","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.clinthera.2014.05.011","article-title":"High-dose intravenous vancomycin therapy and the risk of nephrotoxicity","volume":"36","author":"Rostas","year":"2014","journal-title":"Clin Ther"},{"key":"2020050308275237500_dkaa142-B3","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1093\/jac\/dkt133","article-title":"High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia","volume":"68","author":"Nukui","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2020050308275237500_dkaa142-B4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2169\/internalmedicine.42.665","article-title":"Hyponatremia and\/or hyperkalemia in patients treated with the standard dose of trimethoprim-sulfamethoxazole","volume":"42","author":"Mori","year":"2003","journal-title":"Intern Med"},{"key":"2020050308275237500_dkaa142-B5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1086\/382084","article-title":"Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem","volume":"38","author":"Gerding","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2020050308275237500_dkaa142-B6","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s10096-017-3014-8","article-title":"Emerging multidrug-resistant Bengal Bay clone ST772-MRSA-V in Norway: molecular epidemiology 2004\u20132014","volume":"36","author":"Blomfeldt","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020050308275237500_dkaa142-B7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/jac\/dkz493","article-title":"In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016\u201318","volume":"75","author":"Appalaraju","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2020050308275237500_dkaa142-B8","author":"Niu"},{"key":"2020050308275237500_dkaa142-B9","doi-asserted-by":"crossref","first-page":"e02297","DOI":"10.1128\/AAC.01089-18","article-title":"Intrapulmonary pharmacokinetics of levonadifloxacin following oral administration of alalevonadifloxacin to healthy adult subjects","volume":"62","author":"Rodvold","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2020050308275237500_dkaa142-B10","doi-asserted-by":"crossref","first-page":"e00909","DOI":"10.1128\/AAC.00909-19","article-title":"In vivo pharmacokinetic\/pharmacodynamic targets of levonadifloxacin against Staphylococcus aureus in a neutropenic murine lung infection model","volume":"63","author":"Bhagwat","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2020050308275237500_dkaa142-B11","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.2147\/DDDT.S229882","article-title":"Levonadifloxacin, a novel broad-spectrum anti-MRSA benzoquinolizine quinolone agent: review of current evidence","volume":"13","author":"Bhagwat","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"2020050308275237500_dkaa142-B12","doi-asserted-by":"crossref","first-page":"e0227009","DOI":"10.1371\/journal.pone.0227009","article-title":"Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in methicillin-resistant Staphylococcus aureus: a first report from South India","volume":"14","author":"Bakthavatchalam","year":"2019","journal-title":"PLoS One"},{"key":"2020050308275237500_dkaa142-B13","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1099\/jmm.0.021956-0","article-title":"A simplified multiplex PCR assay for fast and easy discrimination of globally distributed staphylococcal cassette chromosome mec types in meticillin-resistant Staphylococcus aureus","volume":"59","author":"Ghaznavi-Rad","year":"2010","journal-title":"J Med Microbiol"},{"key":"2020050308275237500_dkaa142-B14","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1128\/JCM.38.3.1008-1015.2000","article-title":"Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus","volume":"38","author":"Enright","year":"2000","journal-title":"J Clin Microbiol"},{"key":"2020050308275237500_dkaa142-B15","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1128\/AAC.49.5.2098-2101.2005","article-title":"Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus","volume":"49","author":"Trong","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2020050308275237500_dkaa142-B16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4103\/0974-777X.157245","article-title":"Study of antibiotic resistance pattern in methicillin resistant Staphylococcus aureus with special reference to newer antibiotic","volume":"7","author":"Kaur","year":"2015","journal-title":"J Global Infect Dis"},{"key":"2020050308275237500_dkaa142-B17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmi.2018.09.023","article-title":"Import of community-associated, methicillin-resistant Staphylococcus aureus to Europe through skin and soft-tissue infection in intercontinental travellers, 2011\u20132016","volume":"25","author":"Nurjadi","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2020050308275237500_dkaa142-B18","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1128\/AAC.48.9.3338-3342.2004","article-title":"In vitro activity of the new quinolone WCK 771 against staphylococci","volume":"48","author":"Jacobs","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2020050308275237500_dkaa142-B19","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/AAC.00641-06","article-title":"The anti-methicillin-resistant Staphylococcus aureus quinolone WCK 771 has potent activity against sequentially selected mutants, has a narrow mutant selection window against quinolone-resistant Staphylococcus aureus, and preferentially targets DNA gyrase","volume":"50","author":"Bhagwat","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2020050308275237500_dkaa142-B20","author":"Chugh"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/advance-article-pdf\/doi\/10.1093\/jac\/dkaa142\/33157559\/dkaa142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/advance-article-pdf\/doi\/10.1093\/jac\/dkaa142\/33157559\/dkaa142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T12:28:05Z","timestamp":1588508885000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/advance-article\/doi\/10.1093\/jac\/dkaa142\/5828350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaa142","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,3]]},"article-number":"dkaa142"}}